MS&AD Ventures participated in Axo Longevity's $5M Seed round. Axo Longevity is a preventive health platform providing biomarker testing and personalized health blueprints, based in London and Madrid.
Axo Longevity is a preventive health platform that analyzes over 100 biomarkers to provide personalized health insights and action plans, aiming to optimize long-term health and performance
Axo Longevity is a preventive health platform that analyzes over 100 biomarkers to provide personalized health insights and action plans, aiming to optimize long-term health and performance.